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ABSTRACT Drug-resistant staphylococci, particularly Staphylococcus aureus and Staphy-
lococcus epidermidis, are leading causes of hospital-acquired infections. Bacterio-
phages and their peptidoglycan hydrolytic enzymes (lysins) are currently being
explored as alternatives to conventional antibiotics; however, only a limited di-
versity of staphylococcal phages and their lysins has yet been characterized.
Here, we describe a novel staphylococcal phage and its lysins. Bacteriophage
Andhra is the first reported S. epidermidis phage belonging to the family Podo-
viridae. Andhra possesses an 18,546-nucleotide genome with 20 open reading
frames. BLASTp searches revealed that gene product 10 (gp10) and gp14 harbor
putative catalytic domains with predicted peptidase and amidase activities, char-
acteristic functions of phage lysins. We purified these proteins and show that
both Andhra_gp10 and Andhra_gp14 inhibit growth and degrade cell walls of
diverse staphylococci, with Andhra_gp10 exhibiting more robust activity against
the panel of cell wall substrates tested. Site-directed mutagenesis of its pre-
dicted catalytic residues abrogated the activity of Andhra_gp10, consistent with
the presence of a catalytic CHAP domain on its C terminus. The active site loca-
tion combined with the absence of an SH3b cell wall binding domain distin-
guishes Andhra_gp10 from the majority of staphylococcal lysins characterized to
date. Importantly, close homologs of Andhra_gp10 are present in related staphy-
lococcal podophages, and we propose that these constitute a new class of
phage-encoded lysins. Altogether, our results reveal insights into the biology of
a rare family of staphylococcal phages while adding to the arsenal of antimicro-
bials with potential for therapeutic use.
IMPORTANCE The spread of antibiotic resistance among bacterial pathogens is in-
citing a global public health crisis. Drug-resistant Staphylococcus species, especially
S. aureus and S. epidermidis, have emerged in both hospital and community settings,
underscoring the urgent need for new strategies to combat staphylococcal infec-
tions. Bacterial viruses (phages) and the enzymes that they use to degrade bacterial
cell walls (lysins) show promise as alternative antimicrobials; however, only a limited
variety of staphylococcal phages and their lysins have yet been identified. Here, we
report the discovery and characterization of a novel staphylococcal phage, Andhra.
We show that Andhra encodes two lysins (Andhra_gp10 and Andhra_gp14) that in-
hibit growth and degrade the cell walls of diverse staphylococci, including S. aureus
and S. epidermidis strains. Andhra and its unique lysins add to the arsenal of antimi-
crobials with potential for therapeutic use.
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Pathogenic staphylococci resistant to multiple antibiotics continue to impose aheavy burden on global public health (1). Staphylococcus aureus causes moderate
to fatal infections in a variety of body sites (2), and asymptomatic nasal carriage in over
25% of the population constitutes a major public health risk (3, 4). Staphylococ-
cus epidermidis is a ubiquitous skin commensal and opportunistic pathogen that is
responsible for the majority of infections associated with indwelling medical devices (5).
To compound the high frequency of antibiotic resistance already observed in many
clinical S. epidermidis isolates, these organisms have a propensity to form biofilms,
which aid in surface colonization and provide enhanced tolerance to antibiotics (5).
Drug-resistant staphylococci are a leading cause of hospital-acquired infections (6) and
have more recently emerged in community settings (7), underscoring the urgent need
for alternative approaches to combat staphylococcal infections.
Phages and their peptidoglycan hydrolytic enzymes (lysins) show significant prom-
ise as alternative treatments of staphylococcal infections (8–10). Both phages and their
lysins have several advantages over conventional antibiotics, including their ability to
(i) kill bacteria that are resistant to antibiotics, (ii) target a narrow spectrum of bacterial
pathogens while leaving beneficial microbes unharmed, and (iii) penetrate and dissi-
pate biofilms. All known staphylococcal phages have tubular tails, icosahedral heads,
and double-stranded DNA genomes (11, 12). Based on these features, they have been
classified into three morphological families with characteristic genome lengths: Podo-
viridae (20 kb), Siphoviridae (~40 kb), and Myoviridae (125 kb). Of the ~200 staph-
ylococcal phages reported, the majority (~71%) are temperate with siphophage mor-
phology and a host range limited to S. aureus (12). Temperate phages can form
prophages carrying pathogenesis factors and can promote fitness and pathogenicity
through the mobilization of virulence factors and pathogenicity islands (13). Thus, the
staphylococcal siphophages are unsuitable for whole-phage therapy. Obligatorily lytic
phages that attack staphylococci belong to the families Myoviridae and Podoviridae, of
which myophages are more common and show promise as whole-phage therapeutics
(8, 9). However, phages are replete with uncharacterized genes, which could cause
unexpected downstream side effects. Further, regulatory constraints in Europe and the
United States present challenges to the therapeutic use of phages in humans (14). As
more viable alternatives, purified phage-encoded lysins have been shown to kill
drug-resistant staphylococci in vitro and in animal models (8–10, 15). Moreover, many
of these lysins work synergistically with small-molecule antibiotics and are considered
less likely to promote the evolution of bacterial resistance (10). Since the use of
cocktails of antimicrobials with a variety of targets and multiple modes of action can
more effectively limit the emergence of resistant bacterial strains, we sought to expand
the growing arsenal of staphylococcal phages and their lysins.
Phage isolation. Since fewer than 10 S. epidermidis phages have been reported thus
far (12), and because the clinical isolate RP62a possesses multiple phage defense
mechanisms, including a functional CRISPR-Cas (clustered regularly interspaced short
palindromic repeat) system (16), we used this organism as a host to discover phages
capable of subverting such defenses. Phage Andhra was captured by coculturing
S. epidermidis RP62a with raw sewage and purified by replating individual plaques
several times with this host. Transmission electron microscopy revealed that Andhra
possesses a morphology consistent with members of the rare lytic family Podoviridae
within the genus P68like virus (Fig. 1A; see also Table S1 in the supplemental material).
Phenotypic features. Andhra has a latent period of approximately 30 min and a
burst size of 9.3  2.4 phage particles released per infected cell (Fig. 1B). While plaque
formation is readily apparent on its original host, Andhra causes lysis from without (LO)
on related staphylococci (Table S2). LO is characterized by a general restriction of
growth at the site of phage application on a bacterial lawn, without formation of
plaques (17). A variety of explanations could account for this phenomenon, including
the activity of phage-encoded peptidoglycan hydrolytic enzymes (tail-associated
and/or free-floating lysins) present in the phage preparation. The possibility of broad-
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spectrum activity in its lysin(s) prompted the genomic characterization of phage
Andhra.
Genotypic features. Genomic DNA from Andhra was purified and subjected to
enzymatic digestion (Fig. 1C) and whole-genome sequencing. Digestion with DNase I
and various restriction enzymes confirmed a double-stranded DNA genome. Whole-
genome sequencing revealed that phage Andhra has an 18,546-nucleotide (nt) ge-
nome with 155-nt terminal inverted repeats and 20 predicted open reading frames
(Fig. 1D; Table S3). A BLASTn search using the Megablast algorithm against the whole
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FIG 1 Phenotypic and genotypic features of bacteriophage Andhra. (A) Andhra was stained with uranyl acetate and imaged using
transmission electron microscopy at200,000 magnification. The morphology is consistent with Podoviridae. (B) A one-step growth curve
is shown. S. epidermidis RP62a was challenged with phage Andhra, and PFU were enumerated at 10-min intervals. An average of triplicate
measurements is shown. The latent period is defined as the time between adsorption and the beginning of the first burst, and the burst
size is defined as the ratio of final plaque count to the initial count. (C) Andhra genomic DNA was extracted, subjected to digestion by
the indicated enzymes, and resolved on a 1% agarose gel. Lane M, 1-kb DNA marker; lane -, no enzyme added. (D) A whole-genome
sequence alignment of S. epidermidis phage Andhra with indicated S. aureus podophages was generated using the Mauve software
(http://darlinglab.org/mauve/mauve.html). Homologous genome regions are indicated with similarly colored histograms, and regions that
lack detectible homology remain uncolored. Below the similarity histograms, open reading frames are indicated by block arrows pointing
in the direction of transcription. Specific gene products that are discussed in the text are labeled underneath each open reading frame.
BLASTp was used to assign putative functions for phage Andhra genes, and the GenBank annotations were used for gene function
assignments for the other podophages. Gene products with related functions are similarly colored according to the key at the bottom.
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Andhra genome returned regions of homology in a group of S. aureus podophages,
which share up to 71% identity over 32% of their genomes. Multiple sequence
alignments revealed that Andhra is distantly related to other staphylococcal podophages
(Fig. S1), sharing a central module of conserved core genes, with some unique se-
quences on its peripheries (Fig. 1D). Genome architectures of these phages are also
conserved, with two apparent transcriptional units converging near the center. BLASTp
searches provided functional assignments for 12 out of the 20 gene products in phage
Andhra (Table S3). Similarly to its S. aureus podophage relatives, Andhra exhibits
clustering of genes into related functional groups and apparent conservation of gene
order (Fig. 1D).
Lysins of phage Andhra. BLASTp results predict that gene products 10 and 14
(Andhra_gp10 and Andhra_gp14, respectively) possess catalytic domains with charac-
teristic functions of lysins: Andhra_gp10 harbors a C-terminal CHAP domain with
putative peptidase activity, and Andhra_gp14 possesses a putative Zn-binding amidase
catalytic site on its N terminus. To date, only two staphylococcal podophage lysins have
been characterized in vitro: SAL-2 (18) and PlyGRCS (19), which are encoded by S. aureus
podophages SAP-2 and GRCS, respectively. For simplicity, these will be referred to as
SAP-2_gp14 and GRCS_gp15, respectively (Fig. 1D). While Andhra_gp14 is encoded in
an analogous genomic position, just upstream of phage tail genes (Table S3),
Andhra_gp14 shares little or no homology with SAP-2_gp14 and GRCS_gp15 (~18%
identity according to a Clustal Omega alignment [Fig. S2A]). In contrast, Andhra_gp10
is located in the conserved core region found in other staphylococcal podophages
(Fig. 1D) and shares 68% identity with SAP-2_gp10 and GRCS_gp11 (Fig. S2B), as well
as 44AHJD_gp11 and P68_gp11, hypothetical proteins from 44AHJD and P68, the
prototypical S. aureus podophages. Thus far, none of these proteins have been char-
acterized in vitro.
To test their in vitro activities, recombinant Andhra_gp14 and Andhra_gp10 were
overexpressed in Escherichia coli and purified (Fig. S3A). When combined with live cells,
both proteins inhibited the growth of S. epidermidis and Staphylococcus intermedius
strains, with little or no effect on S. aureus growth (Fig. S3B). To more directly quantify
their ability to degrade cell wall substrates derived from these organisms, a dye-release
assay was used (Fig. 2). In this assay, heat-killed bacterial cells are labeled with Remazol
brilliant blue dye, which covalently links to insoluble cell walls and is released into
solution upon cell wall degradation (20). We observed that both Andhra_gp14 and
Andhra_gp10 degrade the cell walls of these diverse staphylococci, including S. aureus
strains (Fig. 2A to E). Andhra_gp10 exhibited a more robust activity against the tested
strains, with moderate ability to degrade even E. coli cell walls (Fig. 2F).
With few exceptions, the majority of characterized staphylococcal lysins possess an
N-terminal active site(s) and C-terminal SH3b cell wall binding domains (15, 21).
Andhra_gp10 lacks a detectable SH3b domain and instead possesses a predicted active
site on its C terminus. To confirm the active site location, the conserved cysteine (C354)
and histidine (H420) residues of the predicted CHAP domain were changed to alanines
(Fig. S2B), and this mutant variant was purified (Fig. S3A) and tested for activity in vitro
(Fig. 2). While its activity against staphylococcal cell walls was severely impaired,
Andhra_gp10C354A,H420A exhibited an activity comparable to that of the wild type
against E. coli cell walls. These observations are consistent with the presence of a
C-terminal CHAP domain and suggest the possibility of a second distinct active site in
Andhra_gp10, a rare feature of some staphylococcal lysins (15).
Conclusions. Here, we provide the first report of a Podoviridae S. epidermidis phage
and demonstrate growth inhibition and cell wall hydrolytic activities of two of its
enzymes: Andhra_gp14 and Andhra_gp10. Andhra_gp14 exhibits moderate hydrolytic
activity against staphylococcal cell walls and lacks homologs in podophages specific for
S. aureus. These observations, combined with its genomic position adjacent to genes
encoding minor and major tail proteins, support our speculation that Andhra_gp14 is
a tail-associated lysin that aids in adsorption of phage DNA during initial stages of
Cater et al.
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infection. In contrast, Andhra_gp10 is encoded just downstream of a putative holin (a
membrane-degrading enzyme) and exhibits robust hydrolytic activity against the
strains tested, suggesting that this protein is the main lysin used to degrade cell walls
from within the host and facilitate virion escape at the end of the replication cycle.
Andhra_gp10 has a C-terminal CHAP domain and lacks an SH3b cell wall binding
domain, two distinguishing features that make this protein a unique and important
addition to the growing collection of phage-encoded lysins. Homologs of Andhra_gp10
are present in other staphylococcal podophages, and we therefore propose that these
enzymes represent a new class of phage-encoded lysins. Altogether, our results reveal
insights into the biology of a rare family of staphylococcal phages while adding to the
arsenal of antimicrobials with potential for therapeutic use.
Strains and growth conditions. All staphylococcal strains used in this study were
a generous gift from L. A. Marraffini. Staphylococcal strains were cultured in tryptic soy
broth (TSB; Difco). E. coli DH5 and BL21(DE3) Codon Plus cells (EMD Millipore) were
grown in Luria-Bertani broth (LB; Difco) or Terrific broth (Amresco) for protein purifi-
cation. Medium was supplemented with 30 g/ml chloramphenicol [for selection of
E. coli BL21(DE3)] and 50 g/ml kanamycin (for selection of pET28b-His10Smt3-based
constructs). For routine propagation, bacteria were grown at 37°C in an orbital shaker
set to 160 rpm.
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FIG 2 Cell wall hydrolytic activities of Andhra lysins. A dye release assay was used to quantify the cell wall hydrolytic activity of
Andhra_gp14 (14 WT), Andhra_gp10 (10 WT), Andhra_gp10C354A,H420A (10 mut), lysostaphin, or lysozyme. Cell walls from indicated
bacterial strains were labeled with Remazol brilliant blue dye and used as the substrates. Enzymes (3 g) or IMAC buffer (-) was incubated
with an excess of labeled cell wall substrate at 37°C for 3 h. The dye released into the supernatant was quantified by measuring the optical
density of the soluble fraction at 595 nm. The experiment was conducted in triplicate, and average measurements are shown (top). Images
of 96-well plates containing soluble fractions corresponding to each measurement are also shown (bottom).
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Phage isolation and purification. Phage Andhra was isolated from raw sewage
following an enrichment protocol with three consecutive days of coculturing with
S. epidermidis RP62a. Raw sewage was collected from the Hilliard Fletcher wastewater
treatment plant in Tuscaloosa, AL; treated with chloroform (final concentration of 2%);
and vortexed for 1 min. Treated sewage was clarified by centrifugation at 10,000  g
to remove debris. Sewage supernatant was combined with TSB (1:1) and CaCl2 (5 mM).
An overnight culture of S. epidermidis RP62a was diluted into this mixture (1:100) and
incubated overnight at 37°C with agitation. The culture was pelleted at 3,000  g, and
the resulting supernatant was passed through a 0.2-m filter. The filtrate was combined
1:1 with fresh TSB and cocultured with S. epidermidis RP62a twice more as described
above. The lysate recovered after the third overnight coculture was assayed for the
presence of plaques using a double-agar overlay method as follows: heart infusion agar
(HIA; Hardee Diagnostics) prepared at half the recommended concentration was equil-
ibrated to 55°C. Equilibrated HIA plus CaCl2 (5 mM) was combined with an overnight
culture of S. epidermidis RP62a (at a 1:100 final dilution), and 4 ml of this mixture was
overlaid atop tryptic soy agar (TSA) plates containing 5 mM CaCl2. Tenfold dilutions of
lysate were spotted atop the semisolid HIA layer, allowed to air dry, and incubated
overnight at 37°C. A well-separated plaque was picked with a sterile pipette tip,
combined with 1 ml of TSB, and vortexed at high speed for 1 min. The phage
suspension was filtered and spotted on semisolid agar as described above. Individual
plaques were picked and replated at least five times to obtain a purified phage
preparation.
High-titer phage cultivation. High-titer phage lysates for host range analysis and
DNA extraction were prepared by combining 5 to 10 purified plaques into 1 ml of TSB
and vortexing for 1 min. The resulting phage suspension was passed through a 0.2-m
filter and added to 50 ml of fresh mid-log S. epidermidis RP62a cells grown in TSB plus
CaCl2 (5 mM). Cultures were incubated for 3 to 4 h at 37°C in an orbital shaker until
clearing was observed. Lysates were pelleted to remove cell debris, and resulting
supernatant was passed through a 0.2-m filter. Phage titers were determined by
spotting 10-fold dilutions of lysate on semisolid agar as described above. Following
overnight incubation at 37°C, plaques were enumerated and titers were determined as
PFU per milliliter.
Transmission electron microscopy. Phages from 1 ml of high-titer lysate (at least
1  109 PFU/ml) were pelleted using high-speed centrifugation (1 h at 24,000  g) and
washed three times with 1 ml of a 0.1 M ammonium acetate solution. After the third
wash, phage pellets were resuspended in a final volume of 50 l. Five microliters of
phage suspension was applied to a Formvar-coated copper grid and allowed to settle
for 5 min. Excess liquid was wicked away, and phages were stained for 30 s with 2%
uranyl acetate. Grids were air dried and visualized using a Hitachi 7650 transmission
electron microscope located at the University of Alabama Optical Analysis Facility.
One-step growth curve. The one-step growth curve was determined as described
in reference 22 with minor modifications. Briefly, 20 ml of mid-log S. epidermidis RP62a
cells was combined with phage lysate to achieve a multiplicity of infection (MOI) of 0.1.
Phages were allowed to adsorb to the host for 10 min at 37°C without agitation. Cells
were pelleted by centrifugation at 8,000  g for 5 min, washed once with 20 ml of TSB,
and resuspended in 20 ml of fresh TSB. Cells were incubated at 37°C, 200-l samples
were taken at 10-min intervals and pelleted, and supernatant titers were determined
immediately as described above. The experiment was carried out in triplicate. The
latent period was defined as the time period from adsorption to the beginning of
the first burst, and the burst size was calculated as the ratio of plaques observed after
the first burst to that prior to the first burst.
Genomic DNA extraction. Phage DNA was extracted as described previously (23).
Briefly, 20 ml of high-titer phage lysate (1  109 PFU/ml) was incubated with DNase
I and RNase A (10 g/ml of each) for 30 min at 37°C. Ten milliliters of precipitant
solution (30% [wt/vol] polyethylene glycol [PEG] 8000 and 3 M NaCl) was combined
Cater et al.
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with the lysate and incubated at 4°C overnight. Phages were pelleted by centrifugation
for 10 min at 10,000  g and 4°C. The supernatant was carefully decanted, and phage
pellet was resuspended in 500 l of resuspension buffer (5 mM MgSO4, 10 mM EDTA).
The phage suspension was incubated with proteinase K (100 g/ml) at 50°C for 30 min.
The phage suspension was allowed to cool to room temperature and then combined
with the resin contained in the Promega Wizard DNA cleanup kit (catalog no. A7280).
The phage suspension plus resin was inverted several times and applied to a minicol-
umn contained within the kit. The resin retained in the column was washed with 2 ml
of 80% isopropanol and dried by centrifugation at 13,000  g for 2 min, and DNA was
eluted from the resin with 100 l of distilled water (dH2O) preheated to 80°C. The
concentration of recovered DNA was determined using a NanoDrop spectrophotom-
eter.
Genomic DNA sequencing. DNA was sequenced in an Illumina MiSeq 250-bp
paired-end run with a 550-bp insert library at the Genomic Sequencing and Analysis
Facility at the University of Texas (Austin, TX). Quality-controlled trimmed reads were
assembled to a single contig at 136.7-fold coverage. The contig was confirmed to be
complete by PCR using primers that face the upstream and downstream ends of the
DNA. Genes were predicted using SnapGene software.
Plasmid construction. pET28b-His10Smt3-based plasmids expressing Andhra_gp10,
Andhra_gp10C354A,H420A, and Andhra_gp14 were constructed using Gibson assembly
with the primers shown in Table S4. Plasmid pET28b-His10Smt3 was used as a PCR
template for the backbone constructs containing the wild-type proteins, Andhra
genomic DNA was used to amplify the corresponding wild-type phage genes, and
pET28b-His10Smt3-Andhra_gp10 was used as the template to create the construct
containing the Andhra_gp10C354A,H420A mutant. PCR products were purified using the
EZNA Cycle Pure kit (Omega) and Gibson assembled, and resulting plasmids were
transformed into E. coli DH5. Transformants were isolated, and the constructs were
purified and sequenced with primers T7T and T7P (Table S4). Confirmed constructs
were then transformed into E. coli BL21(DE3) Codon Plus cells for protein purification.
Purification of recombinant Andhra_gp14, Andhra_gp10, and Andhra_
gp10C354A,H420A from E. coli. Recombinant proteins were overexpressed and purified
from E. coli BL21(DE3) Codon Plus cells containing the corresponding pET28b overex-
pression constructs as previously described (24) with minor modifications: the pH of
all buffers was adjusted to 6.8 for the purification of Andhra_gp10 and Andhra_
gp10C354A,H420A and to 7.5 for the purification of Andhra_gp14. Additionally, the final
dialysis for all proteins was carried out in IMAC buffer (50 mM Tris-HCl, pH 7.5, 250 mM
NaCl, 10% glycerol, 50 mM imidazole). Final protein concentration was determined
using the Bradford reagent (Bio-Rad), and purity was determined by resolution on a
12% SDS-PAGE gel. Proteins were stored at 20°C in IMAC buffer.
Growth inhibition assay. Overnight staphylococcal cultures were diluted 1:100 in
double-strength TSB plus 1 mM MgCl2. Diluted cultures were distributed into a 96-well
plate (50 l per well), and purified protein (3 g) or IMAC buffer was added into
triplicate wells. The final protein concentration was 40 g/ml. Cells were grown
overnight at 37°C with agitation, and optical density measurements at 600 nm (OD600)
were taken at 15-min intervals in a SpectraMax plate reader (Molecular Devices).
Dye release assay. Cell wall substrates derived from indicated bacterial strains were
prepared and subjected to degradation with phage lysins as described in reference 20
with minor modifications. To prepare cell wall substrates, cells (500 ml) were grown to
mid-exponential phase in TSB and autoclaved in a liquid cycle set to 35 min, and
heat-killed cells were washed once with phosphate-buffered saline (PBS). The cell pellet
was weighed and mixed with a Remazol brilliant blue solution (200 mM Remazol
Brilliant Blue R dye [Sigma] prepared in 250 mM NaOH) at a concentration of 0.5 g cell
pellet in 30 ml of solution. Mixtures were incubated at 37°C for 6 h with agitation and
then transferred to 4°C for 12 h with gentle rocking. Cell wall substrate was centrifuged
at 3,000  g for 30 min, the supernatant was poured off, and the pellet was washed
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March/April 2017 Volume 2 Issue 2 e00040-17 msphere.asm.org 7
 o
n
 Septem
ber 12, 2018 by guest
http://m
sphere.asm
.org/
D
ow
nloaded from
 
with 40 ml dH2O. Cell wall substrate was pelleted and washed as described above
repeatedly (~5 times) until the supernatant became clear and the only coloration in the
tube remained in the cell pellet. To perform the dye release assay, labeled substrate
pellets were resuspended in IMAC buffer plus 1 mM MgCl2. The volume was adjusted
until an optical density (OD) of 2.0 at 595 nm was achieved. Reaction mixtures were
prepared by combining 200 l of substrate suspension with 3 g of enzyme (lyso-
staphin [Ambi Products], lysozyme [Amresco], Andhra_gp10, Andhra_gp10C354A,H420A,
or Andhra_gp14). Triplicate reaction mixtures were prepared for each enzyme treat-
ment and incubated at 37°C for 3 h, with occasional inversion of tubes (once per hour).
Reactions were stopped with the addition of 25 l of ethanol, and cell wall debris was
pelleted by centrifugation at 13,000  g for 5 min. One hundred microliters of
supernatant from each reaction mixture was placed into a 96-well flat-bottom plate.
Plates were imaged and read for OD595.
Accession number(s). The assembled whole-genome sequence of phage Andhra
was deposited in GenBank under accession no. KY442063.
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